Listed

Boston Scientific Corp: Form 10-Q for the period ended Jun 30, 2023

Filed with the SEC on Aug 3, 2023 and accepted by EDGAR at Aug 3, 2023, 16:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-04-01 to 2023-06-30$3.60bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2023-01-01 to 2023-06-30$6.99bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2023-04-01 to 2023-06-30$1.06bnus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2023-01-01 to 2023-06-30$2.10bnus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2023-04-01 to 2023-06-30$2.54bnus-gaap:GrossProfit
Gross profit6 months2023-01-01 to 2023-06-30$4.89bnus-gaap:GrossProfit
Selling, general and administrative3 months2023-04-01 to 2023-06-30$1.35bnus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2023-01-01 to 2023-06-30$2.57bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-04-01 to 2023-06-30$514.0mus-gaap:OperatingIncomeLoss
Operating income6 months2023-01-01 to 2023-06-30$1.07bnus-gaap:OperatingIncomeLoss
Interest expense3 months2023-04-01 to 2023-06-30$70.0mus-gaap:InterestExpense
Interest expense6 months2023-01-01 to 2023-06-30$135.0mus-gaap:InterestExpense
Income tax3 months2023-04-01 to 2023-06-30$156.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2023-01-01 to 2023-06-30$287.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-04-01 to 2023-06-30$270.0mus-gaap:ProfitLoss
Net income6 months2023-01-01 to 2023-06-30$584.0mus-gaap:ProfitLoss
Diluted EPS3 months2023-04-01 to 2023-06-30$0.18us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2023-01-01 to 2023-06-30$0.39us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-04-01 to 2023-06-30$0.18us-gaap:EarningsPerShareBasic
Basic EPS6 months2023-01-01 to 2023-06-30$0.39us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-04-01 to 2023-06-301,456,200,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2023-01-01 to 2023-06-301,451,100,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2023-01-01 to 2023-06-30$848.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2023-01-01 to 2023-06-30$254.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2023-01-01 to 2023-06-30$28.0mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2023-06-30$426.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-06-30$5.89bnus-gaap:AssetsCurrent
Total assetsAt period end2023-06-30$33.60bnus-gaap:Assets
Current liabilitiesAt period end2023-06-30$4.56bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2023-06-30$559.0mus-gaap:DebtCurrent
Shareholders' equityAt period end2023-06-30$18.23bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000885725-23-000043. Last ingested by Listed: Nov 6, 2026, 17:38 ET. Listed shows no prices and gives no investment advice.